Knocking on FXR´s Door: The "Hammerhead"-Structure Series of FXR Agonists – Amphiphilic Isoxazoles with Potent In Vitro and In Vivo Activities

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|14|19|2143-2158

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.14, Iss.19, 2014-10, pp. : 2143-2158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of FXR, PXR and CAR Agonists and Antagonists for Treatment of Liver Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 6, 2012-03 ,pp. : 605-624

Bentham Science Publishers

Access to resources Recommend Favorite

FXR, A Therapeutic Target for Bile Acid and Lipid Disorders

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 8, 2005-08 ,pp. : 719-727

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 19, 2014-10 ,pp. : 2188-2205

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Non-Steroidal FXR Antagonists Development for Therapeutic Applications

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 19, 2014-10 ,pp. : 2175-2187

Bentham Science Publishers

Access to resources Recommend Favorite

Potential therapeutic applications of farnesoid X receptor (FXR) modulators

By Pellicciari Roberto   Gioiello Antimo   Costantino Gabriele  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 333-341

Informa Healthcare

Access to resources Recommend Favorite